BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 16856158)

  • 1. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
    J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute myeloid leukemia in children with Down syndrome].
    Creutzig U; Ritter J; Ludwig WD; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
    Klin Padiatr; 1995; 207(4):136-44. PubMed ID: 7564143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
    Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
    Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI
    Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
    Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG
    Pediatr Blood Cancer; 2008 Jan; 50(1):9-16. PubMed ID: 17252564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
    Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia: clinical and laboratory features.
    Lima CS; Vassalo J; Lorand-Metze I; Bechelli AP; Souza CA
    Haematologia (Budap); 1997; 28(2):85-95. PubMed ID: 9283908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features].
    Takai K; Sanada M; Shibuya H
    Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome.
    Woodard P; Barfield R; Hale G; Horwitz E; Leung W; Ribeiro R; Rubnitz J; Srivistava DK; Tong X; Yusuf U; Raimondi S; Pui CH; Handgretinger R; Cunningham JM
    Pediatr Blood Cancer; 2006 Dec; 47(7):931-5. PubMed ID: 16155933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
    Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
    Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia.
    Rubnitz JE; Razzouk BI; Lensing S; Pounds S; Pui CH; Ribeiro RC
    Cancer; 2007 Jan; 109(1):157-63. PubMed ID: 17133407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
    Tallman MS; Kim HT; Paietta E; Bennett JM; Dewald G; Cassileth PA; Wiernik PH; Rowe JM;
    J Clin Oncol; 2004 Apr; 22(7):1276-86. PubMed ID: 14970186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of micromegakaryocytes in de novo AML].
    Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
    Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of trilinear myelodysplastic syndrome and erythroleukemia.
    Michiels JJ; van der Meulen J; Brederoo P
    Haematologica; 1997; 82(4):452-54. PubMed ID: 9299860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
    Inaba H; Fan Y; Pounds S; Geiger TL; Rubnitz JE; Ribeiro RC; Pui CH; Razzouk BI
    Cancer; 2008 Aug; 113(3):522-9. PubMed ID: 18484648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.
    Lange BJ; Dinndorf P; Smith FO; Arndt C; Barnard D; Feig S; Feusner J; Seibel N; Weiman M; Aplenc R; Gerbing R; Alonzo TA
    J Clin Oncol; 2004 Jan; 22(1):150-6. PubMed ID: 14701777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of prognostic variables in childhood acute myeloid leukemia].
    Gu LJ; Tie LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Ye H; Wang YP; Dong L
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):10-3. PubMed ID: 16732931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia].
    Zou Y; Wang H; Chen XJ; Wang SC; Zhang L; Chen YM; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):621-5. PubMed ID: 17278430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.